Publicaciones Imprimir Bodor JN, Xiu J, Ernani V, Kaur S, Mamdani H, Ou SHI, Ma PC, Borghaei H, Clapper ML, VanderWalde A, Treat J. Brief Report: The Immune Profiles of the Molecular Subtypes of EGFR-Mutant Lung Adenocarcinomas in a Large Real-World Cohort. Clin Lung Cancer. 2024 Nov; 25 (7):e312-e315.e1 Epub 2024 May 03 View PubMed Karigyo CJT, Pessoa BMS, Nicacio SP, Terwilliger E, Costa P, Santos PRD, Ernani V, Seetharam M, Murakami AN, Batalini F. Cardiac Tumors: Review. Braz J Cardiovasc Surg. 2024 Jul 22; 39 (6):e20230405 Epub 2024 July 22 View PubMed Peng Y, Kumar AV, Gu Z, Kosuru N, Wampfler JA, Reck Dos Santos PA, Yu NY, D'Cunha J, Ernani V, Costello CM, Yang P. Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort. J Am Acad Dermatol 2024 Jul; 91 (1):172-175 Epub 2024 Mar 29 View PubMed Peng Y, Ernani V, Liu D, Guo Q, Hopps M, Cappelleri JC, Gupta R, de Andrade M, Chen J, Yi ES, Yang P. Lung adenocarcinoma patients with ROS1-rearranged tumors by sex and smoking intensity. Heliyon. 2024 Apr 15; 10(7):e28285. Epub 2024 Mar 16. View PubMed Rivera-Concepcion J, Lo YC, Uprety D, Adjei AA, Ernani V, Leventakos K. A challenging case of stage IV EGFR-mutant lung cancer with histologic transformation and multiple resistance mechanisms. Current Problems in Cancer: Case Reports. 2024; 13:100284 Desai A, Smith CJ, Ashara Y, Orme JJ, Zanwar S, Potter A, Hocum C, Moffett JN, Schwecke AJ, Manochakian R, Lou Y, Zhao Y, Ernani V, Savvides P, Molina J, Dimou A, Mansfield AS, Parikh K, Leventakos K. Real-World Outcomes With Lurbinectedin in Second-Line Setting and Beyond for Extensive Stage Small Cell Lung Cancer. Clin Lung Cancer. 2023 Dec; 24 (8):689-695.e1 Epub 2023 Sept 17 View PubMed Agarwal M, Liu A, Almquist D, Langlais BT, Leventakos K, Yu NY, Manochakian R, Ernani V. Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status. Cancer. 2023 Nov 15; 129 (22):3546-3553 Epub 2023 Aug 07 View PubMed Agarwal M, Liu A, Langlais BT, Leventakos K, Yu NY, Almquist D, Manochakian R, Ernani V. Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3. Clin Lung Cancer. 2023 Nov; 24 (7):591-597 Epub 2023 May 26 View PubMed Campany ME, Reck Dos Santos PA, Donato BB, Alwardt CM, Ernani V, D'Cunha J, Beamer SE. Hyperthermic intrapleural chemotherapy: an update. J Thorac Dis. 2023 Sep 28; 15 (9):5064-5073 Epub 2023 Aug 11 View PubMed Ernani V, Appiah AK, Rodriguez D, Kusne Y, Beamer SE, Ravanbakhsh S, Jaroszewski D, Reck Dos Santos P, Sio TT, Yu N, Yang P, Schild S, D'Cunha J. Lobar versus sublobar resection for atypical lung carcinoid: An analysis from the National Cancer Database. Cancer. 2023 Mar 15; 129 (6):860-866 Epub 2022 Dec 22 View PubMed Du L, Ernani V, Liu A, Schild SE, Jaroszewski DE, Cassivi SD, Beamer SE, Luo YH, Wampfler JA, Santos PARD, Wigle D, Sun D, Shen KR, Yang P. Prognostic factors in resected pulmonary carcinoid tumors: A retrospective study with 10 years of follow‑up. Oncol Lett. 2023 Feb; 25 (2):80 Epub 2023 Jan 10 View PubMed Dos Santos PAR, Li Y, Ernani V, D'Cunha J, Aubry MC, Yang P. Clinical outcomes of stage-IV non-small-cell lung cancer in young patients and the impact of tumor markers. Cancer Treat Res Commun. 2023; 36:100723 Epub 2023 June 12 View PubMed Desai A, Rakshit S, Bansal R, Ashara Y, Potter A, Manochakian R, Lou Y, Zhao Y, Ernani V, Savvides P, Schwecke A, Moffett N, Hocum C, Leventakos K, Adjei A, Marks R, Molina J, Mansfield AS, Chen ZM, Dimou A. Time from immune checkpoint inhibitor to sotorasib use correlates with risk of hepatotoxicity in non-small cell lung cancer: A brief report. Cancer Treat Res Commun. 2023; 36:100743. Epub 2023 Jul 13. View PubMed Yu NY, DeWees TA, Voss MM, Breen WG, Chiang JS, Ding JX, Daniels TB, Owen D, Olivier KR, Garces YI, Park SS, Sarkaria JN, Yang P, Savvides PS, Ernani V, Liu W, Schild SE, Merrell KW, Sio TT. Cardiopulmonary Toxicity Following Intensity-Modulated Proton Therapy (IMPT) Versus Intensity-Modulated Radiation Therapy (IMRT) for Stage III Non-Small Cell Lung Cancer. Clin Lung Cancer. 2022 Dec; 23 (8):e526-e535 Epub 2022 Aug 10 View PubMed Gao RW, Day CN, Yu NY, Bush A, Amundson AC, Prodduturvar P, Majeed U, Butts E, Oliver T, Schwecke AJ, Moffett JN, Routman DM, Breen WG, Potter AL, Rivera-Concepcion J, Hoppe BS, Schild SE, Sio TT, Lou Y, Ernani V, Ko S, Olivier KR, Merrell KW, Garces YI, Manochakian R, Harmsen WS, Leventakos K, Owen D. Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab. Lung Cancer. 2022 Aug; 170:58-64 Epub 2022 June 13 View PubMed Ernani V, Du L, Ross HJ, Yi JE, Wampfler JA, Schild SE, Xie H, Swanson KL, Tazelaar HD, Yang P. Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long-term survival in limited stage small-cell lung cancer. Thorac Cancer. 2022 Apr; 13 (7):925-933 Epub 2022 Feb 23 View PubMed Yu NY, Sio TT, Ernani V, Savvides P, Schild SE. Role of Prophylactic Cranial Irradiation in Extensive-Stage Small Cell Lung Cancer. J Natl Compr Canc Netw. 2021 Dec; 19 (12):1465-1469 View PubMed Almquist DR, Ernani V, Sonbol MB. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: DIPNECH. Curr Opin Pulm Med. 2021 Jul 1; 27 (4):255-261 View PubMed Owonikoko TK, Dwivedi B, Chen Z, Zhang C, Barwick B, Ernani V, Zhang G, Gilbert-Ross M, Carlisle J, Khuri FR, Curran WJ, Ivanov AA, Fu H, Lonial S, Ramalingam SS, Sun SY, Waller EK, Sica GL. YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype. J Thorac Oncol. 2021 Mar; 16 (3):464-476 Epub 2020 Nov 25 View PubMed Keit E, Coutu B, Zhen W, Zhang C, Lin C, Bennion N, Ganti AK, Ernani V, Baine M. Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer. Ann Transl Med. 2021 Feb; 9 (3):227 View PubMed Almquist D, Ernani V. The Road Less Traveled: A Guide to Metastatic ROS1-Rearranged Non-Small-Cell Lung Cancer. JCO Oncol Pract. 2021 Jan; 17 (1):7-14 Epub 2020 Nov 19 View PubMed Grinnell M, Appiah AK, Baine M, Ernani V, Marr A, Zhang C, Zhen W, Buddharaju LNR, Smith LM, Ganti AK. Adjuvant chemotherapy following SBRT for early stage non-small cell lung cancer (NSCLC) in older patients. J Geriatr Oncol. 2020 Sep; 11 (7):1145-1153 Epub 2020 May 07 View PubMed Ernani V, Jahan R, Smith LM, Marr AS, Kimbrough SE, Kos ME, Tijerina J, Pivovar S, Lakshmanan I, Ketcham M, Rauth S, Mallya K, Nasser MW, Jain M, Kessinger A, Batra SK, Ganti AK. A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study. Cancer Treat Res Commun. 2020; 22:100162 Epub 2019 Oct 07 View PubMed Ernani V, Appiah AK, Baine MJ, Smith LM, Ganti AK. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy. Cancer Treat Res Commun. 2020; 24:100197 Epub 2020 July 21 View PubMed Ernani V, Stinchcombe TE. Management of Brain Metastases in Non-Small-Cell Lung Cancer. J Oncol Pract. 2019 Nov; 15 (11):563-570 View PubMed Ernani V, Appiah AK, Marr A, Zhang C, Zhen W, Smith LM, Ganti AK. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy. J Thorac Oncol. 2019 Mar; 14 (3):475-481 Epub 2018 Nov 29 View PubMed Palacio S, Hosein PJ, Reis I, Akunyili II, Ernani V, Pollack T, Macintyre J, Restrepo MH, Merchan JR, Rocha Lima CM. The nab-paclitaxel/gemcitabine regimen for patients with refractory advanced pancreatic adenocarcinoma. J Gastrointest Oncol. 2018 Feb; 9 (1):135-139 View PubMed Ernani V, Ganti AK. Immunotherapy in treatment naive advanced non-small cell lung cancer. J Thorac Dis. 2018 Feb; 10 (Suppl 3):S412-S421 View PubMed Steuer CE, Behera M, Ernani V, Higgins KA, Saba NF, Shin DM, Pakkala S, Pillai RN, Owonikoko TK, Curran WJ, Belani CP, Khuri FR, Ramalingam SS. Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review. JAMA Oncol. 2017 Aug 1; 3 (8):1120-1129 View PubMed Ernani V, Steuer CE, Jahanzeb M. The End of Nihilism: Systemic Therapy of Advanced Non-Small Cell Lung Cancer. Annu Rev Med. 2017 Jan 14; 68:153-168 Epub 2016 Sept 07 View PubMed Ernani V, Kumar M, Chen AY, Owonikoko TK. Systemic treatment and management approaches for medullary thyroid cancer. Cancer Treat Rev. 2016 Nov; 50:89-98 Epub 2016 Sept 10 View PubMed Kumar M, Ernani V, Owonikoko TK. Biomarkers and targeted systemic therapies in advanced non-small cell lung cancer. Mol Aspects Med. 2015 Nov; 45:55-66 Epub 2015 July 14 View PubMed Ernani V, Saba NF. Oral Cavity Cancer: Risk Factors, Pathology, and Management. Oncology. 2015; 89 (4):187-95 Epub 2015 June 17 View PubMed Chapman-Fredricks J, Blieden C, Sandoval JD, Ernani V, Ikpatt OF. Acute spontaneous tumor lysis syndrome as the initial presentation of ALK-positive diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol. 2014 Apr; 22 (4):317-21 View PubMed Hosein PJ, Macintyre J, Kawamura C, Maldonado JC, Ernani V, Loaiza-Bonilla A, Narayanan G, Ribeiro A, Portelance L, Merchan JR, Levi JU, Rocha-Lima CM. A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma. BMC Cancer. 2012 May 29; 12:199 View PubMed Bustinza-Linares E, Socola F, Ernani V, Miller SA, Trent JC. Extraskeletal myxoid chondrosarcoma with small bowel metastasis causing bowel obstruction. Case Rep Oncol Med. 2012; 2012:621025 Epub 2012 Nov 18 View PubMed Paes FM, Ernani V, Hosein P, Serafini AN. Radiopharmaceuticals: when and how to use them to treat metastatic bone pain. J Support Oncol. 2011 Nov-Dec; 9 (6):197-205 View PubMed Toneto MG, Hoffman A, Conte AF, Schambeck JL, Ernani V, Souza HP. Extended lymphadenectomy (D2) in the treatment for gastric cancer - analysis of postoperative complications. Revista do Colegio Brasileiro de Cirurgioes (Journal of the Brazilian College of Surgeons). 2008; 35(4):228-234. PST-20524600 Inicio Publicaciones